The grant process involves inviting specific scientists to respond to a request for applications (RFA). Once those materials are received they are reviewed by the Medical Advisory Board and the Board of Directors of the Inflammatory Breast Cancer Research Foundation.
In 2010, Bryan P. Schneider, M.D., and doctoral student Milan Radovich of Indiana University studied the underlying molecular underpinning of inflammatory breast cancer using cutting edge technology called Next Generation Sequencing with the support of a $50,000 grant from the Inflammatory Breast Cancer Research Foundation and the Milburn Foundation partnership. Currently, Dr. Schneider is a medical oncologist, Professor of Medicine and Medical/Molecular Genetics at the Indiana University Melvin and Bren Simon Cancer Center, and the Vera Bradley Chair of Oncology. His clinical interests include breast cancer and precision genomics.